John B. Moriarty, EVP & General Counsel at ALEXION PHARMACEUTICALS INC (ALXN), sold 3,326 shares at $131.71 ($438K) on 2017-02-28, disclosed to the SEC on 2017-03-01.
Seasonal sale ($438k) by EVP & General Counsel — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.20 | 612 | $80K | 18.3% |
| 2 | $131.20 | 612 | $80K | 18.3% |
| 3 | $131.71 | 910 | $120K | 27.4% |
| 4 | $131.71 | 910 | $120K | 27.4% |
| 5 | $132.50 | 282 | $37K | 8.5% |
| Total | $131.59 avg | 3,326 |
| $438K |
| 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $639K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $296K | — | Filing → |
| ALXN | SELL | 2017-02-10 | $21K | — | Filing → |